More articles from From the Editor
- IVUS: A better picture of coronary artery disease?
As an end point in a clinical trial, a change on intravascular ultrasonography is somewhere between a change in low-density lipoprotein cholesterol and a change in the mortality rate as evidence of efficacy of treatment.
- Intervention as prevention
True primary prevention of disease or its complications seems an attainable goal in many situations.
- Messing with Mother Nature
Even the most effective, cleverly targeted therapies may come with unintended consequences.
- New CCJM policy: No manufacturer involvement in the preparation of articles
We will not consider for publication any review article in which the manufacturer was involved in the preparation of the manuscript, either directly or through payment to the author or a surrogate.
- Trench foot, jungle rot, and now, Baghdad boil
Those of us in civilian practice need to pay attention to specific problems of our returning troops, so we can expeditiously deal with them in our offices and clinics.
- CCJM’s further evolution
The honor of succeeding Dr. John Clough as Editor-in-Chief comes with the responsibility of shepherding the continued evolution of the Journal.
- Passing the baton
Beginning next month, current deputy editor Brian Mandell, MD, PhD, will assume the role of editor-in-chief of the Cleveland Clinic Journal of Medicine. I have enjoyed my tenure and look forward to continuing my association with the Journal.
- The Vioxx withdrawal: Latest in the COX-2 controversies
Discussion of the COX-2 inhibitors has been emotionally polarized every step of the way, and it’s not over. Two other COX-2 drugs are still available, and much money is at stake.
- Tight inpatient glucose control: Why didn’t we think of this before?
Standardized algorithms to manage chronic diseases such as diabetes in the hospital should get more patients out of the hospital alive.
- A DASH of prevention
The DASH diet is clearly a useful tool for lowering blood pressure in dedicated patients.